- Home
- TCRX vs BYFC Comparison
TCRX vs BYFC Comparison
Compare TCRX & BYFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCRX | BYFC |
|---|---|---|
| Founded | 2018 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.1M | 70.0M |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | TCRX | BYFC |
|---|---|---|
| Price | $1.19 | $8.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 554.3K | 17.3K |
| Earning Date | 03-04-2026 | 01-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $8,423,000.00 | ★ $32,386,000.00 |
| Revenue This Year | $286.83 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.88 | $5.51 |
| 52 Week High | $2.67 | $8.85 |
Technical Indicators
Market Signals| Indicator | TCRX | BYFC |
|---|---|---|
| Relative Strength Index (RSI) | 57.52 | 71.09 |
| Support Level | $1.09 | $8.03 |
| Resistance Level | $1.27 | $8.79 |
| Average True Range (ATR) | 0.08 | 0.43 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 70.81 | 88.80 |
Price Performance
Historical ComparisonAbout TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About BYFC Broadway Financial Corporation
Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.